Use of Anti–Tumor Necrosis Factors and Anti-Integrins in the Treatment of Crohn's Disease
Author:
Publisher
Elsevier BV
Subject
Gastroenterology
Reference62 articles.
1. Inflammatory bowel disease;Abraham;N Engl J Med,2009
2. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials;Peyrin-Biroulet;Clin Gastroenterol Hepatol,2008
3. Complications and surgery in the inflammatory bowel diseases biological era;Sokol;Curr Opin Gastroenterol,2014
4. Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis;Costa;Inflamm Bowel Dis,2013
5. Update on anti-tumor necrosis factor agents in Crohn disease;Singh;Gastroenterol Clin North Am,2014
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug survival and adherence to biologic agents in patients with inflammatory bowel disease from a large health maintenance organization;2024-04-11
2. Review article: emerging drug therapies in inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2022-02-15
3. Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience;Saudi Journal of Gastroenterology;2022
4. Novel and Emerging Therapies for Inflammatory Bowel Disease;Frontiers in Pharmacology;2021-04-14
5. Therapie mit monoklonalen Antikörpern in der Gastroenterologie;Der Internist;2019-09-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3